Erectile Dysfunction

(See: "Lilly Buys Out Cialis Partner".)While most of Lilly's brand drug sales increased slightly from a year ago, its depression fighter Cymbalta was booming.

Sales in the first quarter were $441.8 million, up 89.4% or $233.3 million, from a year ago.

The company began enjoying a boost in prescriptions mid-way last year after it re-launched the brand with a new direct-to-consumer advertising campaign.

(See: "Lilly Shares Discount Rebound For Zyprexa, Cymbalta".) On top of higher consumer awareness, the company has benefited from a growing preference by physicians.

Doctors have started to differentiate the drug from other anti-depressants because of its ability to treat pain.

(See: "Lilly's Cymbalta Could See Market Share Gains".)More On This Topic The Mystery Of Pfizer's Toxic Pill Companies: LLY -% String xsl=(String) application.getAttribute(com.forbes.cms.Constants.XSL_REP_KEY)+"/story_body_html_trans.xsl"; final TransformerFactory tFactory = TransformerFactory.newInstance(); final Transformer transformer = tFactory.newTransformer(new StreamSource(xsl)); final ByteArrayOutputStream bao = new ByteArrayOutputStream(); byte[] bytes = transformedStoryStr.getBytes(); ByteArrayInputStream input=new ByteArrayInputStream(bytes); InputStream myInput=(InputStream)input; try{ transformer.transform(new StreamSource(myInput), new StreamResult(bao)); }catch (Exception...

Read more...